Jasper Therapeutics Files 8-K
Ticker: JSPRW · Form: 8-K · Filed: Jul 7, 2025 · CIK: 1788028
| Field | Detail |
|---|---|
| Company | Jasper Therapeutics, Inc. (JSPRW) |
| Form Type | 8-K |
| Filed Date | Jul 7, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, corporate-update
Related Tickers: JSPR
TL;DR
Jasper Therapeutics filed an 8-K on 7/7/25. Standard reporting.
AI Summary
Jasper Therapeutics, Inc. filed an 8-K on July 7, 2025, reporting on other events and financial statements. The company, formerly known as Amplitude Healthcare Acquisition Corp, is incorporated in Delaware and operates in the biological products sector.
Why It Matters
This filing provides an update on Jasper Therapeutics' corporate activities and financial reporting, which is important for investors to stay informed about the company's status.
Risk Assessment
Risk Level: low — This is a routine 8-K filing for reporting purposes and does not indicate any unusual or high-risk events.
Key Players & Entities
- Jasper Therapeutics, Inc. (company) — Registrant
- Amplitude Healthcare Acquisition Corp (company) — Former Company Name
- July 7, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
FAQ
What is the primary business of Jasper Therapeutics, Inc.?
Jasper Therapeutics, Inc. is involved in the biological products sector, specifically classified under 'BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)' with SIC code 2836.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on July 7, 2025.
What was Jasper Therapeutics, Inc. formerly known as?
Jasper Therapeutics, Inc. was formerly known as Amplitude Healthcare Acquisition Corp.
In which state is Jasper Therapeutics, Inc. incorporated?
Jasper Therapeutics, Inc. is incorporated in Delaware.
What is the business address of Jasper Therapeutics, Inc.?
The business address of Jasper Therapeutics, Inc. is 2200 Bridge Pkwy Suite #102, Redwood City, CA 94065.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 7, 2025 regarding Jasper Therapeutics, Inc. (JSPRW).